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Use of Negative Pressure Wound Therapy after
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CASE REPORT
Abstract—We present a case report of a patient suffering
from Diabetic Foot Syndrome (DFS) of ischemic etiology. The
patient developed toe and dorsal foot tissue necrosis, underwent
a revascularization procedure and subsequently amputation of
the necrotic tissues. The patient was treated with vacuum
therapy. During the hospitalization, despite microbial monitoring
of the wound and use of wide spectrum antibiotics according to
antimicrobial susceptibility testing (AST), a generalization of the
infection occurred and septic shock symptoms followed what in
the end resulted in high limb amputation.
Keywords—V.A.C., Diabetic Foot Syndrome, lower limb angio-
plasty, sepsis, septic shock.
I. INTRODUCTION
D IABETES, aside from obesity, arterial hypertension, andchronic obstructive pulmonary disease, is one of the
most prevalent diseases. It is estimated that in Europe 2–
5% of the general population suffers from diabetes. In some
world regions, the disease has reached an epidemic status.1
It often develops asymptomatically due to deep ischemia of
the extremities and disturbance of pain sensation, caused by
nervous system impairment.
Every week 100 people with DFS lose a foot due to
complicated ulcerations and the frequency of amputations
caused by non-healing ulcers or necrosis is 60–85%.2, 3 Inter-
national Diabetes Federation (IDF) estimates that 382 million
people suffer from diabetes all over the world, including 3
million in Poland alone. Every 6 seconds a person dies due
to complications of diabetes.3 According to Polish Diabetic
Association, Poland is in the group of countries performing
the highest number of extremity amputations, and additionally
30,000 patients die annually due to diabetes.4
DFS is the result of a poorly managed diabetes. We recog-
nize neuropathic, vascular and mixed forms of DFS. According
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Figure 1. The mid-foot ulcer before first surgical intervention
to the Kings College Hospital in London, 62% of patients suf-
fer from neuropathic DFS 13% from a vascular type and 25%
from mixed type DFS. Symptoms of ischemic etiology DFS
are rest pain especially during the night, localized in the distal
part of the lower extremity. The pain decreases after lowering
of the limb and increases with lower limb edema. On the other
hand the neuropathic DFS is characterized by cold sensation,
numbness, increased skin temperature, visibly engorged veins,
muscle tremor, cramps and crushing sensation. In comparison
to vascular DFS pain, this one is constant, disseminated, with
episodes of massive aggravation. It escalates into allodynia and
subsequently disappears after the total nervous disruption. All
of those changes are steps that could be indicative of ongoing
gangrene or skin ulceration process. The proper treatment
protocol is supported by basic laboratory parameters, wound
swab culture (in order to identify the main pathogen), as
well as confirmation of infection duration and DFS etiology.
Prolonged waiting time, and conservative treatment may result
in deep fulminant infection possibly leading to sepsis, high
limb amputation and death.5–13
The efficacy of ulcerative changes treatment was evaluated
in many previous publications. Those did not however in-
clude aspects of fulminant septic symptoms that often lead
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to amputation. In the case of mixed DFS, deep progressive
limb ischemia is probable even in the absence of symptoms.
This condition provides consequently a favorable environment
for the growth of bacteria, what can then lead to progressive
infection, sepsis and often the death of the patient. The modern
way to treat deep wound infections is with the use of vacuum
therapy (VAC).14–16 In this paper, we present a complex case of
combination therapy, in which we failed to rescue the patient’s
limb.
II. CASE REPORT
A 60-year-old patient was admitted to the hospital emer-
gency department due to necrotic lesions of the dorsal surface
of the toes as well as dorsal- and the lateral side of the foot.
The patient suffered from type II diabetes for an unspecified
time period. Outpatient medical treatment consisted of the
topical application of a broad spectrum antibiotic ointment.
About three weeks after the first symptoms appeared, the
patient was admitted to the hospital. Necrotic lesions were
defined as stage IV according to the classification of Wagner.
Patient concomitantly suffered from hypertension and smoked
30 cigarettes per day for 40 years, leading a sedentary lifestyle.
His Body Mass Index was about 32. Pulse was palpable over
the femoral arteries, poorly palpable over the right popliteal
artery, and not palpable on the arteries of the foot. Ankle
Brachial Index was 0.8. Patient was diagnosed with ischemic
DFS with dry ulcer with necrosis, swelling and inflammation
of the forefoot and midfoot, which did not extend to II and
IV toes. This resulted in swelling and excessive calor of the
entire foot. See figure 1.
After hospital admission, we ordered microbiological
wound tests, which indicated Pseudomonas aeruginosa in-
fection. Intravenous targeted antibiotic therapy was initiated:
Augmentin (at a dose of 2.4 g per day) and Gentamicin (at a
dose of 160 mg per day).
In less than a few hours after admission to the hospital,
we were forced to order an urgent angiography — numerous
major vascular constriction of the lower limb became apparent.
The right popliteal artery in the P2 segment was constricted
in 70%, the tibial artery in 80%, and sagittal artery — 90%.
These changes were reversed after the application of percu-
taneous balloon angioplasty of all above-mentioned arteries.
Additionally, 75 mg of clopidogrel daily was administered. We
were able to achieve a significant improvement in peripheral
circulation, pulse over peripheral arteries, as well as improve-
ment of peripheral distal limb’s perfusion. See figure 2.
We then performed a rapid debridement of the ulcer by
removing of necrotic and purulent material within the healthy
tissues. VAC dressings were applied on such prepared wound
bed to remove excessive secretions as well as improve blood
circulation and reduce swelling. Dressing changes were per-
formed every 2–3 days. See figure 3.
During second dressing change, additional debridement was
performed. A noticeably better perfusion of the distal limb
tissues was observed. See figure 4.
During third dressing change (nine days since admission)
we diagnosed necrosis of the toes III–V. We decided to
Figure 2. Angiography: arrows show a marked arterial constriction, which was
resolved by percutaneous balloon angioplasty. Negligible flow to peripheral
arteries is visible.
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Figure 3. The first fitting of the vacuum dressing, removal of all possibly
necrotic tissues.
Figure 4. The second debridement of necrotic lesions on the sixth day of
admission. Significant improvement in limb blood flow.
amputate these with wide debridement of the ischemic tissues.
See figure 5.
The eleventh day after admission to the hospital, (between
the third and fourth dressing change) VAC dressing decom-
pression occurred, which resulted in the accumulation of pus
in the deep wound layers. Inadequate resealing of the dressing,
conducted by a nurse team, without the doctor’s supervision,
probably allowed for the rapid development of bacterial out-
growth. The event took place during the weekend, at the time
the patient was in an unconditioned room with high interior
temperature.
Over the next three days the edema and inflammatory
infiltration progressed. Along with these changes hectic fever
of up to 40.2◦ C, tachypnoea, and fatigue at rest occurred.
Laboratory work-up demonstrated an increase in the number
of leukocytes to about 18,000 / mL and high C-reactive protein
(CRP) level (from 50 mg/L to about 230 mg/L within 3 days).
Procalcitonin has reached a level of >400 ng/mL. 4 days
after the dressing decompression, consciousness, and cognitive
disorders occurred. All these factors including the patient’s
clinical state pointed to the emergence of a generalized infec-
tion and septic shock symptoms. In order to save the patient’s
life, we were forced to perform a high amputation of the lower
limb. See figure 6.
III. DISCUSSION
Undiagnosed or poorly managed diabetes can lead to the
development of ischemia, atherosclerosis, or neurological dis-
orders. One of the chronic complications of diabetes is DFS,
which affects not only the health of the patient, but it can also
threaten his life. Many cases of DFS are accompanied by an
infection which very often is multifactorial.2, 17–19
During hospitalization, the patient was treated with targeted
antibiotics according to AST results. We re-vascularized is-
chemic tissues, eliminated necrosis out of the wound bed and
used vacuum dressings which we changed every 2–3 days.
We also evaluated the possibility of wound closure using skin
grafts or dermal flap reposition with simultaneous treatment
of concomitant diseases which we eventually abandoned.
Microbial cultures of infected leg ulcers often indicate
Gram-negative bacteria colonization (57.2%, Enterococcus,
Enterobacteriaceae, Pseudomonas aeruginosa) and Gram-
positive (42.8%) mainly Streptococcus and Staphylococcus
as well as anaerobic bacteria and fungi.5, 15, 17, 18, 20–22 Sta-
tistically, we most often deal with wound colonization by
Pseudomonas aeruginosa (in 21.43% of symptomatic patients)
and Staphylococcus aureus (17.86% of respondents).4 Thus, it
is difficult to choose the right antibiotic, without knowing the
type of pathogen present in the wound.
In the described case, prolonged prehospital treatment based
on broad spectrum antibiotics in insufficient doses was incor-
rect, which could have favored the accumulation of necrosis.
The literature suggests that the risk of amputation increases
with the duration of the disease and with each day of conser-
vative treatment.23
In the case of DFS, changes occur in tunica media, leading
to calcification, which causes narrowing of the lumen or
even total obstruction of the artery.24 Balloon angioplasty of
the main lower limb arteries improves the blood circulation
and nutrient supply to the wound, what reduces the time
of treatment. It reduces the risk of wound recurrence while
Figure 5. The necessity of II to V toes amputation occurred. Proper blood
circulation in the limb visible (b).
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Figure 6. Significant deterioration in the blood supply to the limb (a). One
of the stages of limb amputation (b).
endovascular treatment is often the last chance to save the limb
from amputation.3, 14, 18, 24 Endovascular treatment begins to
gain an important role in the treatment of DFS and should be
applied in combination with surgical approach.25, 26
In the above case we were dealing with a mixed type of
DFS, with a significantly increased risk of sepsis. Ulcers with
a small outer diameter often may mask more serious lesions
in the deeper tissues that would require extensive radical
debridement. The mean treatment duration of DFS ulcers takes
approximately 3–5 months. Implementation of the vacuum
dressings changed every 2–3 days, combined with surgical
wound debridement has reduced this time to approximately 1
month.17, 27 Wachal et al. estimated that the average treatment
time using this method is reduced to 19 days.14
One of the principles of this approach is the close coopera-
tion of all medical staff members, both doctors as well as the
nursing staff. The well-trained medical team should understand
the phenomena taking place in the ischemic limb and respond
quickly in case of vacuum dressing leaks.13, 28 Leaving the
wound covered by a sealing film in an unconditioned room
where the temperature exceeds 25◦ C will inevitably lead to
a rapid outgrowth of bacteria, which can turn into a rapidly
progressive sepsis leading to a septic shock.
There is general agreement that the use of VAC dressings
improved blood circulation and promotes wound granulation
process. Armstrong et al. estimated in their work, that applica-
tion of negative pressure dressings in patients with leg ulcers
and DFS increased the chance of total recovery by 17% when
compared with the group of patients treated conservatively —
pharmacologically.13, 15, 28–30
It is estimated that about 750,000 people worldwide die each
year from complications of severe sepsis or septic shock. Mor-
tality despite the introduction of the latest standards, ranges
from 30–60% of patients. Gierek et al. showed, that in the
group of 646 intensive care unit (ICU) patients (during 2008–
2009) 7.0% were diagnosed with severe sepsis (3 patients) or
septic shock (42 patients) and 29 patients died (57.7%).31 In
Poland, the incidence and mortality of sepsis are significant.
According to the Polish Sepsis Working Group’s study, the
prevalence of severe sepsis is approximately 14.6% of patients
treated in the ICUs while the diagnosis of septic shock could
be made in 6% of those patients.22 People who die due to sep-
sis, are often affected by concomitant diseases: cardiovascular
disease, atrial fibrillation, coronary heart disease, hypertension,
diseases of the pancreas, chronic renal failure or diabetes.31
In the pathological evolution of septic shock, the symptoms
of sepsis are accompanied by hypotension with impaired tissue
perfusion.22 In our patient, about 4 days after vacuum dressing
decompression CRP levels, procalcitonin levels and leukocyte
numbers significantly increased. We observed respiratory as
well as consciousness disorders and drop in blood pressure.
Our decision to perform lower limb amputation was due to
the ongoing significant deterioration of the clinical condition,
and occurrence of the septic shock indicators. By remov-
ing the source of infection, clinical state improvement was
achieved.32, 33
During the Open Diabetes Leadership Forum, which was
held in Beijing in 2009, Kofi Annan said: "Throughout the
world, the threat of diabetes is ignored and under-funded.
Fighting diabetes must be a priority. The problem is so serious
that we all need to get involved if we want to prevent the
epidemic wave". We agree with these words. Fast action, the
right management and adequate training of the medical team
are the most important aspects affecting the proper treatment
of DFS.
REFERENCES
[1] M. Kozierska-Rosciszewska, Cukrzyca u osob starszych diagnostyka,
leczenie, prewencja powiklan. Zaklad Medycyny Rodzinnej i Medycyny
Spolecznosci Lokalnej: Uniwersytet Medyczny w Lodzi.
[2] B. Ducka and K. Strojek, “Rola diabetologa w zapobieganiu rozwojowi
stopy cukrzycowej,” Przewodnik Lekarza, vol. 4, pp. 43–51, 2007.
[3] Niebieska Ksiega Cukrzycy, Warszawa, 2013.
[4] A. Neneman, M. Deja, H. Kubisiak-Rzepczyk, T. Miroszewska-
Sobanska, L. Kurek, M. Szarata, and A. Z., “Wplyw cukrzycy na
wystepowanie i przebieg owrzodzen podudzi, ze szczegolnym uwz-
glednieniem zakazen bakteryjnych i grzybiczych,” Nowiny Lekarskie,
vol. 75, no. 6, pp. 505–511, 2006.
[5] A. Korzon-Burakowska and S. Tecza, “Infekcje w przebiegu zespolu
stopy cukrzycowej,” Diabetologia Praktyczna, no. 2, pp. 92–96, 2005.
[6] M. Eneroth, J. Apelqvist, and A. Stenstrom, “Clinical characteristics
and outcome in 223 diabetic patients with deep foot infections,” Foot &
Ankle International, vol. 18, no. 11, pp. 716–722, nov 1997. [Online].
Available: http://dx.doi.org/10.1177/107110079701801107
[7] R. E. Pecoraro, G. E. Reiber, and E. M. Burgess, “Pathways
to diabetic limb amputation: Basis for prevention,” Diabetes Care,
vol. 13, no. 5, pp. 513–521, may 1990. [Online]. Available:
http://dx.doi.org/10.2337/diacare.13.5.513
[8] L. G. Newman, “Unsuspected osteomyelitis in diabetic foot ulcers,”
JAMA, vol. 266, no. 9, p. 1246, sep 1991. [Online]. Available:
http://dx.doi.org/10.1001/jama.1991.03470090080036
[9] G. E. Reiber, “Risk factors for amputation in patients with diabetes
mellitus,” Annals of Internal Medicine, vol. 117, no. 2, p. 97, jul 1992.
[Online]. Available: http://dx.doi.org/10.7326/0003-4819-117-2-97
[10] M. L. Grayson, G. W. Gibbons, G. M. Habershaw, D. V. Freeman, F. B.
Pomposelli, B. I. Rosenblum, E. Levin, and A. W. Karchmer, “Use
of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of
limb-threatening foot infections in diabetic patients,” Clinical Infectious
Diseases, vol. 18, no. 5, pp. 683–693, may 1994. [Online]. Available:
http://dx.doi.org/10.1093/clinids/18.5.683
[11] B. R. Shah and J. E. Hux, “Quantifying the risk of infectious diseases
for people with diabetes,” Diabetes Care, vol. 26, no. 2, pp. 510–513,
feb 2003. [Online]. Available: http://dx.doi.org/10.2337/diacare.26.2.510
12 NEGATIVE PRESSURE WOUND THERAPY JOURNAL, VOL. 2, NO. 2, 2015
[12] J. Wrobel and J. Connolly, “Making the diagnosis of osteomyelitis.
the role of prevalence,” Journal of the American Podiatric Medical
Association, vol. 88, no. 7, pp. 337–343, jul 1998. [Online]. Available:
http://dx.doi.org/10.7547/87507315-88-7-337
[13] G. Oszkinis, M. Gabriel, F. Pukacki, and W. Majewski, Leczenie ran
trudno gojacych sie. Warszawa: Blackhorse Scientific Publishers, 2006.
[14] K. Wachal, B. Lyszyk, and M. Kozak, “Rola nowoczesnych opatrunkow
w leczeniu zespolu stopy cukrzycowej’,” Med. Metab: T., vol. 16, no. 1,
pp. 88–90, 2012.
[15] K. Wachal, K. Karas, M. Stanisic, Z. Krasinski, R. Staniszewski,
and G. Oszkinis, “Ocena skutecznosci leczenia chorych z zespolem
stopy cukrzycowej po pierwotnej amputacji w zakresie stopy z powodu
zmian martwiczych, leczonych technika "otwarta" z zastosowaniem
opatrunkow podcisnieniowych’,” Acta Angiol., vol. 18, no. Suppl. A,
p. A48, 2012.
[16] K. Wachal, R. Staniszewski, W. Majewski, K. Pawlaczyk-Gabriel, and
B. Lyszyk, Ocena zastosowania terapii VAC u chorych z zespolem
stopy cukrzycowej o etiologii niedokrwiennej z dokonanymi zmianami
martwiczymi w obrebie tkanek glebokich.
[17] K. Wachal, R. Staniszewski, W. Majewski, and R. Juszkat, “Ocena
skutecznosci zabiegow rewaskularyzacyjnych u pacjentow z zespolem
stopy cukrzycowej leczonych jednoczesnie terapia vac,” Acta Angiol,
vol. 16, no. Suppl. A, p. A68, 2010.
[18] M. Gabriel, K. Pawlaczyk, G. Oszkinis, F. Pukacki, P. Checinski,
M. Zielinski, and K. Wachal, “Zmiana podatnosci allogenicznych
przeszczepow naczyniowych implantowanych w srodowisku zaka-
zonym,” Acta Angiol, vol. 11, no. 1, pp. 73–74, 2005.
[19] A. Berent and B. Lipsky, “Zakazenie kosci i stawow w przebiegu stopy
cukrzycowej,” Medycyna po Dyplomie, vol. 1, pp. 38–52, 2004.
[20] A. Korzon-Burakowska, “Zespol stopy cukrzycowej - patogeneza i
praktyczne aspekty postepowania,” Choroby Serca i Naczyn, vol. 4,
no. 2, pp. 93–98, 2007.
[21] A. Sekowska and E. Gospodarek, “Zakazenie stopy cukrzycowej -
analiza mikrobiologiczna,” Pielegniarstwo Chirurgiczne i Angiologiczne,
vol. 4, pp. 119–122, 2010.
[22] [Online]. Available: https://pneumonologia.wum.edu.pl/sites/
pneumonologia.wum.edu.pl/files/sepsa.pdf
[23] E. Wojcik, “Zespol stopu cukrzycowej pod nadzorem,”
Diabetologiaonline.pl. [Online]. Available: http://diabetologiaonline.
pl/pielegniarka_artykuly.info.207.html
[24] M. Sojka, T. Jargiello, A. Wolski, M. Gornik, K. Karska, and
M. Szczerbo-Trojanowska, “Leczenie wewnatrznaczyniowe zespolu
stopy cukrzycowej,” Postepy Nauk Medycznych, no. 5, pp. 428–433,
2012.
[25] F. B. Pomposelli, N. Kansal, A. D. Hamdan, A. Belfield, M. Sheahan,
D. R. Campbell, J. J. Skillman, and F. W. Logerfo, “A decade
of experience with dorsalis pedis artery bypass: Analysis of
outcome in more than 1000 cases,” Journal of Vascular Surgery,
vol. 37, no. 2, pp. 307–315, feb 2003. [Online]. Available:
http://dx.doi.org/10.1067/mva.2003.125
[26] M. S. Conte, D. F. Bandyk, A. W. Clowes, G. L. Moneta, L. Seely, T. J.
Lorenz, H. Namini, A. D. Hamdan, S. P. Roddy, and M. Belkin, “Results
of PREVENT III: A multicenter, randomized trial of edifoligide for
the prevention of vein graft failure in lower extremity bypass surgery,”
Journal of Vascular Surgery, vol. 43, no. 4, pp. 742–751.e1, apr 2006.
[Online]. Available: http://dx.doi.org/10.1016/j.jvs.2005.12.058
[27] K. Wachal, W. Majewski, A. Kopydlowska, Z. Turowiecka, E. Wojtasin-
ska, K. Ciepluch, K. Zawilska, M. Cieszko, and N. Majewska, “Czestosc
wystepowania pierwotnego zespolu antyfosfolipidowego u chorych z
obwodowymi zaburzeniami w tetnicach konczyn dolnych lub gornych,”
Acta Angiol, vol. 14, no. Suppl. A, p. A47, 2008.
[28] I. Robaczewska, M. Filanowicz, and B. Cegła, “Pielegniarskie działania
oparte na stosowaniu specjalistycznych opatrunków ratujacych stope
cukrzycowa,” Pielegniarstwo Polskie, vol. 1, no. 51, pp. 41–48, 2014.
[29] G. Rosin´ski, “Profilaktyka i leczenie zakaz˙en´ stopy cukrzycowej —
stanowisko polskich ekspertów,” Zakazenia, no. 1, pp. 94–99, 2006.
[30] G. Rosinski, “Leczenie zespolu stopy cukrzycowej (zsc),” Przewodnik
Lekarza, no. 3, pp. 58–64, 2005.
[31] D. Gierek, M. Kuczera, J. Dabek, D. Pilat, and A. Kurtok-Nowak,
“Analiza leczenia chorych z ciezka sepsa na oddzialach anestezjologii i
intensywnej terapii górnos´laskiego centrum medycznego,” Anestezjolo-
gia Intensywna Terapia, vol. XLIII, no. 1, pp. 22–28, 2011.
[32] N. Wrzesinska, “Wstrzas septyczny.” [Online]. Available: http:
//wylecz.to/pl/choroby/uklad-krazenia/wstrzas-septyczny.html
[33] T. Targowski and T. Plusa, “Leczenie i profilaktyka sepsy,” Przewodnik
Lekarza, no. 1, pp. 195–197, 2008.
Krzysztof Karas´, M.D. studied in the Poznan´ Uni-
versity of Medical Sciences (PUMS) and in 2011
receieved the Medal for Scientific and Social Work,
given by the President of PUMS.
He previously studien at the Christian Al-
brecht’s University, Faculty of Medicine, Kiel, Ger-
many (as an ERASMUS student) and Univerität-
sklinikum Schleswig-Holstein Klinik fur Herz Und
Gefäßchirurgie.
Since 2013 he works at the Surgical Deprtment
in the Public Hospital in Gniezno (Poland). He is
currently doing his Ph.D. and his hobbies are extreme sports, sky diving,
long-distance cross country running and Krav Maga.
